- The U.S. Food and Drug Administration has declined to reduce the severity of its warning about neuropsychiatric side effects associated with Pfizer Inc's quit-smoking drug Chantix, the agency said on Monday.
- The U.S. Food and Drug Administration has declined to reduce the severity of its warning about neuropsychiatric side effects associated with Pfizer Inc's quit-smoking drug Chantix, the agency said on Monday.
Subscribe our Email News Letter to get Instant Update at anytime
OASES News is a News Agency with the central idea of diseminating credible, evidence-based, impeccable news and activities without stripping all technicalities involved in news reporting.